| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S002770050124 |
| P698 | PubMed publication ID | 8534764 |
| P2093 | author name string | D Hoelzer | |
| A Ganser | |||
| A Böhme | |||
| P2860 | cites work | Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients. | Q33239181 |
| Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions | Q36753802 | ||
| Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses | Q38269547 | ||
| Reversal of daunorubicin resistance in P388/ADR cells by itraconazole | Q40340521 | ||
| Oral azole drugs as systemic antifungal therapy | Q40796244 | ||
| Treatment of invasive aspergillosis with itraconazole | Q46380526 | ||
| Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. | Q53532763 | ||
| Itraconazole and multidrug resistance: possible effects on remission rate and disease-free survival in acute leukemia. | Q54231423 | ||
| Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study | Q72283506 | ||
| P433 | issue | 6 | |
| P921 | main subject | neurotoxicity | Q3338704 |
| toxic encephalopathy | Q7830379 | ||
| P304 | page(s) | 311-312 | |
| P577 | publication date | 1995-12-01 | |
| P1433 | published in | Annals of Hematology | Q15766509 |
| P1476 | title | Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL. | |
| P478 | volume | 71 |
| Q41284012 | Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients. |
| Q35076156 | Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health. |
| Q35936943 | Adverse interactions between antifungal azoles and vincristine: review and analysis of cases. |
| Q39401025 | An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia |
| Q92865754 | Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review |
| Q32060480 | Clinical experience with itraconazole in systemic fungal infections |
| Q33858325 | Effects of the antifungal agents on oxidative drug metabolism: clinical relevance |
| Q35082766 | Impairments that influence physical function among survivors of childhood cancer |
| Q35001199 | Induction of CYP3A4 by Vinblastine: Role of the Nuclear Receptor NR1I2 |
| Q34104641 | Interaction of common azole antifungals with P glycoprotein |
| Q36012864 | Interactions between antiretrovirals and antineoplastic drug therapy. |
| Q39558031 | P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier. |
| Q35070963 | Role of itraconazole in haematology/oncology |
| Q38111391 | Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review |
Search more.